DALE STEPHEN 4
4 · Kura Oncology, Inc. · Filed Jan 31, 2024
Insider Transaction Report
Form 4
DALE STEPHEN
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-01-29$17.80/sh−4,400$78,322→ 46,400 total - Sale
Common Stock
2024-01-29$17.80/sh−2,758$49,094→ 43,642 total - Sale
Common Stock
2024-01-30$21.55/sh−4,825$103,980→ 38,817 total
Footnotes (4)
- [F1]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.
- [F2]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23.
- [F3]This transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2022.
- [F4]This transaction was executed in multiple trades at prices ranging from $18.53 to $22.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.